Ventripoint Diagnostics Stock EBITDA
| VPTDF Stock | USD 0.10 0.01 9.09% |
VentriPoint Diagnostics fundamentals help investors to digest information that contributes to VentriPoint Diagnostics' financial success or failures. It also enables traders to predict the movement of VentriPoint OTC Stock. The fundamental analysis module provides a way to measure VentriPoint Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to VentriPoint Diagnostics otc stock.
VentriPoint |
VentriPoint Diagnostics OTC Stock EBITDA Analysis
VentriPoint Diagnostics' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current VentriPoint Diagnostics EBITDA | (3.82 M) |
Most of VentriPoint Diagnostics' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VentriPoint Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, VentriPoint Diagnostics reported earnings before interest,tax, depreciation and amortization of (3.82 Million). This is 100.44% lower than that of the Healthcare sector and 100.59% lower than that of the Medical Devices industry. The ebitda for all United States stocks is 100.1% higher than that of the company.
VentriPoint EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses VentriPoint Diagnostics' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of VentriPoint Diagnostics could also be used in its relative valuation, which is a method of valuing VentriPoint Diagnostics by comparing valuation metrics of similar companies.VentriPoint Diagnostics is currently under evaluation in ebitda category among its peers.
VentriPoint Fundamentals
| Return On Equity | -1.35 | |||
| Return On Asset | -0.64 | |||
| Operating Margin | (124.50) % | |||
| Current Valuation | 28.27 M | |||
| Shares Outstanding | 156.51 M | |||
| Shares Owned By Insiders | 1.75 % | |||
| Price To Earning | 68.00 X | |||
| Price To Book | 8.27 X | |||
| Price To Sales | 897.04 X | |||
| Gross Profit | (6.27 K) | |||
| EBITDA | (3.82 M) | |||
| Net Income | (3.88 M) | |||
| Cash And Equivalents | 7.29 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 125.38 K | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 6.74 X | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (3.15 M) | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 17 | |||
| Beta | 0.28 | |||
| Market Capitalization | 32.09 M | |||
| Total Asset | 9.54 M | |||
| Retained Earnings | (20.43 M) | |||
| Working Capital | (1.99 M) | |||
| Current Asset | 1.07 M | |||
| Current Liabilities | 3.05 M | |||
| Net Asset | 9.54 M |
About VentriPoint Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze VentriPoint Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VentriPoint Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VentriPoint Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in VentriPoint OTC Stock
VentriPoint Diagnostics financial ratios help investors to determine whether VentriPoint OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in VentriPoint with respect to the benefits of owning VentriPoint Diagnostics security.